Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial
Clinical trial NCT07198451 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07198451
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-05-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.